Future of Optimal Maintenance Therapy in ES-SCLC

The final episode synthesizes the evolving evidence supporting maintenance therapy in extensive stage small cell lung cancer. Key themes include interpretation of IMforte data, patient selection criteria, toxicity management, and long term treatment planning. The discussion considers how maintenance strategies align with current guideline frameworks and ongoing research efforts. Broader implications for frontline treatment sequencing and future therapeutic development are also explored. The episode concludes with an overview of how maintenance therapy may contribute to incremental improvements in disease control within an aggressive malignancy characterized by historically limited survival gains. The summary reflects the shifting treatment paradigm in ES SCLC as evidence continues to expand.